Advancing innovation in non-invasive algorithm technology
For Physicians and Labs
Assisting healthcare professionals in disease diagnosis and monitoring for early intervention
For CROs and Sponsors
Improving cost efficiency in clinical trial recruitments with non-invasive solutions
Non-invasive Diagnostics for Liver Disease
Eliminate the need for risky invasive procedures and suboptimal ultrasounds. Our non-invasive tools combine our proprietary algorithm with common biomarkers, providing high accuracy in liver disease detection.
Screening Tools for Liver Disease
Imaging technologies typically performed during screening procedures are suboptimal, resulting in high screen failure rates. Our screening tools offer risk stratification to help screen patient populations. This filters out patients who are likely to fail during more invasive, costly screening procedures such as ultrasounds.
Fibronostics has screened more than 10,000 patients with our LIVERFASt select and HealthFACTR tools, providing us with a global database of patients at high risk for a variety of diseases.For more information on our patient registry, contact us here
Risk Assessment for Liver Disease
Liver health assessments are often forgotten in corporate wellness, despite 30 percent of the adult population in the U.S. living with some degree of liver disease. Our proprietary algorithm alerts employees to risk factors for liver disease and encourages them to intervene before disease onset.
Risk Assessment for Cardiovascular & Metabolic Diseases
Our health assessment tool examines risk for heart disease, stroke and diabetes, as well as provides action-oriented recommendations which allows employees to make healthier choices.